January 5, 2023
The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
September 20, 2021
The study will assess if PET/CT scans can help identify patients who may have better outcomes from adding customized therapy to standard-of-care treatment
February 12, 2020
The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.